Grazyna Klupińska

Grazyna Klupińska

Auto-generated profile, based on publicly available information

Grazyna Klupińska

Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University, 1 Haller's Square, 90-647 Lodz, Poland

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EWEwa Walecka-Kapica
Ewa Walecka-Kapica
JCJan Chojnacki
Jan Chojnacki
ASAgnieszka Stępień
Agnieszka Stępień
PWPatrycja Wachowska-Kelly
Patrycja Wachowska-Kelly
GKGrażyna Klupińska
Grażyna Klupińska
CCCezary Chojnacki
Cezary Chojnacki
Estrogen deficiency is considered to be the main cause of increased appetite and increased weight in postmenopausal women. In this period, reduced secretion of melatonin (MEL) was also observed. The aim of the study was to evaluate the secretion of melatonin, 17-β estradiol and follicle-stimulating hormone (FSH) in relation to body mass index (BMI) in pre- and postmenopausal women. The study included 90 women divided into three equal groups: group I (control)—women without menstrual disorders, group II—postmenopausal women without change in appetite and body weight, group III—postmenopausal women experiencing increased appetite and weight gain. In each patient, serum melatonin, 17-β-estradiol, FSH and urine a 6-sulfatoxymelatonin (aMT6s) were determined. Compared to the control group, the level of melatonin and estradiol was statistically lower. The FSH level was higher than in the groups of postmenopausal women. No significant correlation was found in all groups between the level of melatonin and the levels of estradiol and FSH. A negative correlation was found between aMT6s excretion and BMI, and a positive correlation between the level of FSH and BMI, mainly in overweight women. The obtained results indicate a significant effect of melatonin deficiency on the process of weight gain in postmenopausal women and justify its use in treatment of these disorders.

1 January 2013
Verified
Journal Article
Closed access
CCCezary Chojnacki
Cezary Chojnacki
EWEwa Walecka-Kapica
Ewa Walecka-Kapica
KŁKatarzyna Łokieć
Katarzyna Łokieć
MPMonika Pawłowicz
Monika Pawłowicz
KWKatarzyna Winczyk
Katarzyna Winczyk
GKGrażyna Klupińska
Grażyna Klupińska

Verified
Journal Article
Open access
PDF file
CCCezary Chojnacki
Cezary Chojnacki
TPTomasz Popławski
Tomasz Popławski
Janusz BlasiakJanusz Blasiak
Janusz Blasiak
JCJan Chojnacki
Jan Chojnacki
GKGrazyna Klupinska
Grazyna Klupinska
Two clinical forms of functional dyspepsia (FD) are listed in the Rome III criteria: postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS), differing in the recurrence of ailments depending on the diet. Continuous EPS (CEPS) is observed in some EPS patients, also at night, but its cause is still unknown. We showed previously that melatonin (MEL) homeostasis may be associated with FD. In the present work we evaluated selected components of melatonin homeostasis in patients with CEPS. The study included 30 patients with CEPS, 21 women and nine men, aged 21–49 years and 30 control subjects (EPS excluded); organic and mental diseases, as well as Helicobacter pylori infection, were excluded in both groups. The average severity of abdominal pain in the last three months was estimated in a 10-point scale (Visual Analog Scale). The levels of mRNA expression of arylalkylamine-N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase (HIOMT), the main components of MEL homeostasis, were determined in gastric mucosa with real time PCR. The fasting serum level of MEL (at 09:00 a.m.) and circadian urine excretion of 6-sulfatoxymelatonin (6-HMS) were determined with ELISA. AANAT expression in antral mucosa of control subjects was 1.76 ± 0.41, in the gastric body 1.35 ± 0.38, and in the dyspeptic group 1.42 ± 0.38 (p < 0.05) and 0.92 ± 0.55 (p < 0.05), respectively. HIOMT expression in the control was 2.05 ± 0.70 in the antrum and 1.57 ± 0.69 in the body and in the CEPS group, it was: 1.51 ± 0.57 (p < 0.05) and 0.74 ± 0.31 (p < 0.001), respectively. MEL concentration (pg/mL) was 9.41 ± 3.09 in the control group and 5.62 ± 1.34 (p < 0.01) in the CEPS group. Urinary 6-HMS excretion (μg/24 h) was 11.40 ± 4.46 in the controls and 7.68 ± 2.88 (p < 0.05) in the CEPS. Moreover, a negative correlation was found between the tested parameters and severity of epigastric pain. These results indicate that patients with CEPS may display low level of AANAT and HIOMT expression in gastric mucosa, resulting in decreased MEL synthesis.

1 August 2011
Verified
Journal Article
Closed access
CCCezary Chojnacki
Cezary Chojnacki
EWEwa Walecka-Kapica
Ewa Walecka-Kapica
GKGrazyna Klupinska
Grazyna Klupinska
MPMonika Pawłowicz
Monika Pawłowicz
AFAntoni Florkowski
Antoni Florkowski
JCJan Chojnacki
Jan Chojnacki

1 May 2009
Verified
Journal Article
Closed access
GKGrazyna Klupińska
Grazyna Klupińska
TPTomasz Popławski
Tomasz Popławski
JSJanusz Smigielski
Janusz Smigielski
Janusz BlasiakJanusz Blasiak
Janusz Blasiak
JCJan Chojnacki
Jan Chojnacki

1 May 2009
Verified
Journal Article
Closed access
EWEwa Walecka-Kapica
Ewa Walecka-Kapica
GKGrazyna Klupińska
Grazyna Klupińska
KSKrystyna Stec-Michalska
Krystyna Stec-Michalska
KOKamila Olszowiec
Kamila Olszowiec
MPMonika Pawłowicz
Monika Pawłowicz
CCCezary Chojnacki
Cezary Chojnacki